University of Cambridge
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


T-Therapeutics
13 Nov 2025
T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.


NoBACZ
30 Sept 2025
NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.


Robin AI
14 Nov 2024
Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures
Robin AI develops legal AI software for large enterprises that analyses, summarises and extracts insights from complex contracts and documents, supporting due diligence, compliance and incident response at scale.
University of Cambridge
More venture news
- 17 Feb 2026


SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
ExtensionEnterprise - 13 Nov 2025

T-TherapeuticsT-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
ExtensionLife Sciences - 19 Nov 2025

PhysicsXPhysicsX secures Series B extension from NVentures to advance new software stack for AI-native engineering
ExtensionDeep Tech